ArticleEClinicalMedicine2024

Maintenance therapy with trofosfamide, idarubicin and etoposide in patients with rhabdomyosarcoma and other high-risk soft tissue sarcomas (CWS-2007-HR): a multicentre, open-label, randomised controlled phase 3 trial.

Ewa Koscielniak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.